Actionable insights straight to your inbox

Equities logo

Progenics Pharmaceuticals Inc. Files SEC Form S-8, Securities To Be Offered To Employees in Employee Benefit Plans (Jun. 27, 2014)

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission

By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Progenics Pharmaceuticals Inc. (Form S-8) was posted on June 27, 2014.
The SIC code for this company is 2834, Pharmaceutical Preparations.
There were 5 documents filed with this form. The SEC file number is 0000835887-14-000078.
The contact information for this company is 777 OLD SAW MILL RIVER ROAD, TARRYTOWN NY 10591, 9147892800.
Our editors provided additional information about Form S-8: This form is used for the registration of securities to be offered to an issuer’s employees pursuant to certain plans.
A U.S. Securities and Exchange Commission filing is a formal document or financial statement submitted to the SEC by publicly-traded companies.
For additional information on this SEC filing see: http://www.sec.gov/Archives/edgar/data/835887/0000835887-14-000078-index.html.
Keywords for this news article include: Pharmaceutical Preparations, Progenics Pharmaceuticals Inc., SEC Filing.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

The Fed model compares the return profile of stocks and US government bonds.